Author

Matthew Butler 1

1 Topivert Pharma Ltd, London, United Kingdom

NARROW SPECTRUM KINASE INHIBITORS (NSKI) TARGET KINASES INVOLVED IN BOTH INNATE AND ADAPTIVE IMMUNE RESPONSES LEADING TO POTENT AND HIGHLY EFFICACIOUS EFFECTS IN EXPERIMENTAL MODELS OF INFLAMMATORY BOWEL DISEASE

Sameer Sirohi, Yemisi Solanke, Matthew Butler, Martyn Foster, Matthew Fyfe, Paolo Biancheri, Thomas Thornton MacDonald, Steve Webber, Claire Walshe

Item 1 - 1 / 1
1